NEW YORK / Oct 31, 2024 / Business Wire / MultiPlan Corporation (NYSE:MPLN), a leading provider of data-driven cost management solutions that deliver transparency and promote fairness, quality and affordability to the U.S. healthcare industry, is accepting applications for its Rural Health Grant now through December 15, 2024 from rural healthcare providers in the U.S. The grants provide financial resources to introduce or expand services, education, screenings and other programs aimed at improving the health of people in their communities.
The MultiPlan Rural Health Grant is available to hospitals, rural health clinics and federally qualified health centers participating in any of MultiPlan’s healthcare provider networks, including PHCS, PHCS Medicaid, MultiPlan, MultiPlan Medicare Advantage, Beech Street, HealthEOS, Texas True Choice, IHP, AMN, HMN and RAN. Eligible providers will be notified by mail or email. An application for the grant is also posted on MultiPlan’s website at https://www.multiplan.com/philanthropic-programs.
The total grant money will be allocated to one or more providers. During the review of the grant applications, the MultiPlan grant committee will determine the award amounts and number of recipients. Grant recipients will be announced in February 2025.
MultiPlan introduced the program in 1995 and has helped fund health services supporting a variety of initiatives, including safety upgrades to a passenger bus that will transport patients to appointments in rural Alabama. Information about grant recipients is available on the MultiPlan website. For questions about the grant, contact MultiPlan at This email address is being protected from spambots. You need JavaScript enabled to view it..
About MultiPlan
MultiPlan is committed to bending the cost curve in healthcare by delivering transparency, fairness, and affordability to the US healthcare system. Our focus is on identifying medical savings, helping to lower out-of-pocket costs, and reducing or eliminating balance billing for healthcare consumers. Leveraging sophisticated technology, data analytics, and a team rich with industry experience, MultiPlan interprets customers’ needs and customizes innovative solutions that combine its payment and revenue integrity, network-based, data and decision science, and analytics-based services. MultiPlan delivers value to more than 700 healthcare payors, over 100,000 employers, 60 million consumers, and 1.4 million contracted providers. For more information, visit multiplan.com.
Last Trade: | US$7.11 |
Daily Change: | -0.86 -10.79 |
Daily Volume: | 79,135 |
Market Cap: | US$114.970M |
November 05, 2024 October 03, 2024 May 08, 2024 |
Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MOREImmix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB